Report date: Jan 21,2025 Conflict count: 358585 Publisher: Elsevier Title count: 957 Conflict count: 17588 ========================================================== Created: 2025-01-04 15:16:25 ConfID: 7766904 CauseID: 1664550786 OtherID: 1451631711 JT: Drug Metabolism and Disposition MD: ,37,10,2118,2009,CORRECTION TO “CHARACTERIZATION OF DASATINIB AND ITS STRUCTURAL ANALOGS AS CYP3A4 MECHANISM-BASED INACTIVATORS AND THE PROPOSED BIOACTIVATION PATHWAYS” DOI: 10.1124/dmd.37.10.2118(Journal) (7766904-N) DOI: 10.1016/S0090-9556(24)02196-2(Journal) ========================================================== Created: 2025-01-04 15:01:42 ConfID: 7766884 CauseID: 1664549121 OtherID: 1451631738 JT: Drug Metabolism and Disposition MD: ,36,8,1736,2008,CORRECTION TO “IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP2B6 INHIBITORS IN WOOHWANGCHEONGSIMWON SUSPENSION, AN HERBAL PREPARATION USED IN THE TREATMENT AND PREVENTION OF APOPLEXY IN KOREA AND CHINA” DOI: 10.1124/dmd.36.8.1736(Journal) (7766884-N) DOI: 10.1016/S0090-9556(24)01767-7(Journal) ========================================================== Created: 2025-01-04 15:23:56 ConfID: 7766885 CauseID: 1664551664 OtherID: 1451631652 JT: Drug Metabolism and Disposition MD: ,38,7,1258,2010,Correction to “5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic Parameters” DOI: 10.1124/dmd.38.7.1258(Journal) (7766885-N) DOI: 10.1016/S0090-9556(24)02420-6(Journal) ========================================================== Created: 2025-01-04 14:54:31 ConfID: 7766864 CauseID: 1664548269 OtherID: 1451631715 JT: Drug Metabolism and Disposition MD: ,36,1,203,2008,CORRECTION TO “USE OF ISOLATED HEPATOCYTE PREPARATIONS FOR CYTOCHROME P450 INHIBITION STUDIES: COMPARISON WITH MICROSOMES FOR KI DETERMINATION” DOI: 10.1124/dmd.36.1.203(Journal) (7766864-N) DOI: 10.1016/S0090-9556(24)01550-2(Journal) ========================================================== Created: 2025-01-04 14:52:36 ConfID: 7766844 CauseID: 1664548154 OtherID: 1453829342 JT: Drug Metabolism and Disposition MD: ,35,11,2138,2007,CORRECTION TO “IN VITRO METABOLIC STUDY OF TEMSIROLIMUS: PREPARATION, ISOLATION, AND IDENTIFICATION OF THE METABOLITES” DOI: 10.1124/dmd.35.11.2138(Journal) (7766844-N) DOI: 10.1016/S0090-9556(24)01497-1(Journal) ========================================================== Created: 2025-01-04 14:48:00 ConfID: 7766824 CauseID: 1664547622 OtherID: 1453829312 JT: Drug Metabolism and Disposition MD: ,35,7,1246,2007,CORRECTION TO “THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF HUMAN CYP51 INHIBITORS” DOI: 10.1124/dmd.35.7.1246(Journal) (7766824-N) DOI: 10.1016/S0090-9556(24)01363-1(Journal) ========================================================== Created: 2025-01-04 14:46:00 ConfID: 7766804 CauseID: 1664547572 OtherID: 1453829281 JT: Drug Metabolism and Disposition MD: ,35,5,829,2007,Correction to “Stereoselective Metabolism of Endosulfan by Human Liver Microsomes and Human Cytochrome P540 Isoforms” DOI: 10.1124/dmd.35.5.829(Journal) (7766804-N) DOI: 10.1016/S0090-9556(24)01301-1(Journal) ========================================================== Created: 2025-01-04 16:56:01 ConfID: 7766964 CauseID: 1664561627 OtherID: 1451631536 JT: Drug Metabolism and Disposition MD: ,40,12,2382,2012,Correction to “In Vivo-Formed versus Preformed Metabolite Kinetics of trans-Resveratrol-3-sulfate and trans-Resveratrol-3-glucuronide” DOI: 10.1124/dmd.40.12.2382(Journal) (7766964-N) DOI: 10.1016/S0090-9556(24)06191-9(Journal) ========================================================== Created: 2025-01-04 16:55:56 ConfID: 7766944 CauseID: 1664561616 OtherID: 1451631536 JT: Drug Metabolism and Disposition MD: ,40,12,2381,2012,Correction to “Stereochemical Aspects of Itraconazole Metabolism In Vitro and In Vivo” DOI: 10.1124/dmd.40.12.2381(Journal) (7766944-N) DOI: 10.1016/S0090-9556(24)06190-7(Journal) ========================================================== Created: 2025-01-04 15:47:40 ConfID: 7766924 CauseID: 1664553984 OtherID: 1453829573 JT: Drug Metabolism and Disposition MD: ,33,5,696,2005,CORRECTION TO “BIOACTIVATION OF THE NONTRICYCLIC ANTIDEPRESSANT NEFAZODONE TO A REACTIVE QUINONEIMINE SPECIES IN HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROME P450 3A4” DOI: 10.1124/dmd.33.5.(Journal) (7766924-N) DOI: 10.1016/S0090-9556(24)11759-X(Journal)